Monthly Archives: April 2009

India approaches WTO against EU on drug seizure issue

April 29th, 2009|

India has complained to the World Trade Organisation against some of the European nations confiscating Indian generic drugs being shipped to South America and Africa via Europe.     

Dip in US drug sales may hit Indian cos

April 29th, 2009|

The pharma industry tracking body, the US-based IMS Health, has highlighted that pharma sales in the US are likely to decline by 1-2% y-o-y this year.

Growth in exports to regulated markets will boost pharma logistics business in India: Experts

April 29th, 2009|

The pharmaceutical logistics business is poised to grow at a faster pace in the near future with the growth of generic market opportunities the Indian companies expected to leverage in the regulated western markets, say supply chain experts.

GSK calls for public health emergency of global concern

April 28th, 2009|

GlaxoSmithKline (GSK) is closely monitoring the situation regarding the emergence of a new influenza A (H1N1) strain in Mexico, the United States of America, Canada, France, Spain and New Zealand. The World Health Organization (WHO) has stated that the current situation constitutes a public health emergency of international concern and they have raised their level of influenza surveillance globally.

US FDA authorizes emergency use of flu medicines, diagnostic test to tackle Swine flu outbreak in hu

April 28th, 2009|

The US Food and Drug Administration, in response to requests from the US Centers for Disease Control and Prevention, has issued Emergency Use Authorizations Read more: (EUAs) to make available to public health and medical personnel important diagnostic and therapeutic tools to identify and respond to the swine flu virus under certain circumstances. The agency issued these EUAs for the use of certain Relenza and Tamiflu antiviral products, and for the rRT-PCR Swine Flu Panel diagnostic test.

Ayurveda 2009′ to take off on May 23 in Colombo

April 28th, 2009|

Ministry of Indigenous Medicine and the Department of Ayurveda, Sri Lanka, is organizing the 'Ayurveda 2009'- the biggest international exhibition and symposium on indigenous healthcare in Sri Lanka at the Bandaranaike Memorial International Conference Hall (BMICH), Colombo from May 23 – 25 2009.

Ardea inks US dollars 407M cancer drug pact with Bayer

April 28th, 2009|

San Diego-based Ardea Biosciences is pocketing a $35 million upfront payment and stands to earn another $372 million in milestones from a cancer drug development pact that it struck with Bayer HealthCare.

Pfizer may buy RFCL’s veterinary co for Rs 250 cr

April 28th, 2009|

GlobaL pharma giant Pfizer has emerged as the frontrunner to acquire RFCL’s animal health unit, Vetnex, in a deal estimated around Rs 250 crore, people familiar with the situation said. This follows the ICICI Venture-controlled RFCL’s move to divest its animal health business earlier this year.

Sun Pharma gets CNBC-TV18 & DHL’s ‘Outstanding Exporter 2008-09’ award

April 28th, 2009|

Sun Pharmaceutical, a Mumbai-based Rs 3350 crore pharmaceutical giant and India's fastest growing international speciality pharma company, has received award in Outstanding Pharmaceuticals, Healthcare & Life Sciences category at the 3rd DHL and CNBC-TV18 International Trade Awards 2008-2009. These awards recognise the efforts of organisations and individuals who have driven India's growth engine in global trade and taken 'Brand India' to the world.

Indian Pharma Primed For Growth

April 26th, 2009|

Pharmaceutical firms are defying a broad-based slowdown in Indian exports. Growing demand for cheap, generic drugs is proving a particular boon, reflected in a 46% year-on-year rise in exports to the U.S. during December, the last month for which finalized data are available.Firms hope to capture a share of the $100 billion worldwide market for generic drugs.

India emerges as best option for contract manufacturing: Global Pharmatech Chief

April 26th, 2009|

Contract manufacturing is one of the best options for the global pharma companies to look forward to in the wake of global recession. The attraction for the global companies to choose India as the ideal hub for contract manufacturing is the opportunity of submission of increasing number of drug master files which has grown to almost 46 per cent in 2007 from a mere 14 per cent in 2000.

Not too enticing

April 26th, 2009|

Good growth prospects, high current prices, lack of support from financial institutions will translate to lukewarm response to the open offers.

MNCs oppose affordable patented drugs

April 26th, 2009|

Governments efforts to bring in affordable patented medicines for chronic and lifestyle ailments may hit a roadblock with multinational companies trying to stall the more.

Govt gives diplomatic push to pharma exports to Africa

April 26th, 2009|

India has started a diplomatic exercise to counter a ‘propaganda’ by multinational pharmaceutical companies against Indian generics or off-patent drugs exported to Africa.

Pfizer, MVV ink pact to fight against malaria

April 26th, 2009|

Pfizer Inc and Medicines for Malaria Venture (MVV) have signed an agreement that is designed to facilitate advancements in the battle against malaria, a disease that afflicts vulnerable populations in the developing world each year.

Sun Pharma arm gets USFDA nod

April 26th, 2009|

Sun Pharmaceutical Industries US arm has obtained a final approval from US Food and Drug Administration (US-FDA) to market Bethanechol Chloride drug on prescription basis.

US FDA approves monthly injectable drug Simponi for three types of immune-related arthritis

April 26th, 2009|

The US Food and Drug Administration approved Simponi (golimumab), a monthly treatment for adults with moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis.

Indian Pharma: Biotech R & D consolidating & downsizing to maintain productivity: Expert

April 26th, 2009|

The pharmaceutical and biotechnology industry is in the process of consolidating and down-sizing while trying to maintain R&D productivity. Small and medium-sized companies are trying to make the most of available opportunities in niche segments.

India to begin campaign to allay fears in African nations about quality of generics

April 23rd, 2009|

The Indian government's aggressive campaign to counter the multinational companies' (MNCs) propaganda against the Indian generic drugs in African countries will start on April 24 in Delhi with an interactive 'clarification meeting' between Indian authorities and the diplomats from the African countries. Ambassadors and high commissioners of African countries in India are participating in the meeting.

Indian cos eye Japan as next generic export market as margins decline in US, EU

April 23rd, 2009|

Increased price erosion and market saturation in US, EU and Asia-Pacific countries have forced Indian pharma majors to look at Japan, which is the world's second largest market for generics after US. Companies plan to cash in on the lucrative generics space as a logical progression in their international forays.